Skip to main content

Companies implementing Health Economics Outcomes Research (HEOR)

HEOR blends economic and outcomes analyses with traditional clinical data—such as efficacy, safety, and quality—to assist decision‑makers in determining patient access to drugs and services.

2,513

companies

List of companies that implement Health Economics Outcomes Research (HEOR)

This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →

CompanyCountryIndustryEmployeesRevenueTechnologies

United States

Pharmaceutical Manufacturing

39k

$46B

Health Economics Outcomes Research (HEOR)

United States

Biotechnology Research

6.4k

$7.6B

Health Economics Outcomes Research (HEOR)

United States

Pharmaceutical Manufacturing

60k

$26B

Health Economics Outcomes Research (HEOR)

Switzerland

Pharmaceutical Manufacturing

102k

$51B

Health Economics Outcomes Research (HEOR)

France

Pharmaceutical Manufacturing

93k

$46B

Health Economics Outcomes Research (HEOR)

United Kingdom

Pharmaceutical Manufacturing

83k

Health Economics Outcomes Research (HEOR)

United States

Hospitals and Health Care

93k

$14B

Health Economics Outcomes Research (HEOR)

Germany

Pharmaceutical Manufacturing

53k

$26B

Health Economics Outcomes Research (HEOR)

United States

Pharmaceutical Manufacturing

109k

$100B

Health Economics Outcomes Research (HEOR)

Switzerland

Research Services

130k

$44B

Health Economics Outcomes Research (HEOR)

Showing top companies out of 2,513 that implement Health Economics Outcomes Research (HEOR). Get the full list on TheirStack.

Frequently asked questions